To this aim we: 1) used breast cancer cell lines with low and high Met expression and activation; 2) used several cell lines in each group to highlight Met activation features which are not cell line specific; 3) measured short and intermediate temporal changes in gene expression following Met activation by HGF/SF and 4) used multiple replications to ensure data integrity. This evidence concerns the gene HGF and breast carcinoma.